BioLargo CEO Interviewed at The Wall Street Resource

BioLargo comments on recent unauthorized third-party promotional activity pursuant to OTC Markets

BioLargo Breaks New Revenue Records and Pays off Variable Priced Debt
BioLargo, Inc. Announces FDA 510(k) Clearance for Clyra Medical Technologies with Stock Day Podcast
BioLargo Signs Memorandum of Understanding with BKT and City of Daegu
BioLargo Water and Sunworks Farm Preparing for First Commercial AOS Trial
BioLargo Subsidiary Clyra Medical Technologies Receives FDA 510(k) Clearance
BioLargo Second Quarter Report Highlights Continued Progress, New Revenue, Contracts, Pilot Projects
BioLargo Welcomes Waste Industry Veteran Mitch Noto to its Team
BioLargo Water Begins Demonstration Pilot for its Advanced Oxidation System (AOS)
BioLargo Engineering Awarded Additional U.S. Air Force Subcontract
BioLargo Engineering Awarded U.S. Air Force Subcontracts
BioLargo’s CupriDyne Clean Eliminates Cannabis Odors - Third-Party Validated Study
BioLargo Quarterly Report Highlights Commercial Progress
BioLargo Engineering Awarded EPA Grant to Develop Methods to Remove Toxic Contaminants from Water
BioLargo's Odor-No-More Enters Cannabis and Hemp Odor Control Industry with Experienced Partner
BioLargo Letter to Stockholders Highlights the Impact of its Innovative Technology Assets
BioLargo Supplies Odor and VOC Control Solution to Cannabis Industry
Uptick Newswire Hosts BioLargo, Inc.’s CEO to Discuss the Company’s Outlook for 2019
BioLargo Letter to Stockholders on Revenue Records in 2018 and Forecasted Positive Cash Flow in 2019
